Cyclodextrin complexation of selected tyrosine kinase inhibitors
The comprehensive physicochemical characterization and cyclodextrin complexation of four tyrosine kinase inhibitors — erlotinib, gefitinib, vandetanib, and lapatinib — were
Tag: kinase inhibitors
Intelligent Drug design Platforms in Cancer Research (online workshop from Taipei University)
Date: 26 February 2026 Programme: (20 February, 9:00-10.25 CET The workshop will take place online via Microsoft Teams. •Registration is